Fed's quiet shift signals market volatility & higher rates. Bond traders face burn, eyeing oil prices.
SpaceX inks $6.3B AI deal with Reflection. High growth potential, but watch valuation risks.
BP med recall hits 11K bottles! Potential ineffectiveness sparks FDA action. Risk looms for pharma.
Google backs A24 with $75M for AI research. High potential returns, but AI's creative impact remains a valuation wildcard.
Micron's profit growth nears 1000%! Traders eye $1700 setup amid memory boom, but AI frenzy may pose market risks.
11K+ BP med bottles recalled for failed dissolution specs. Risk to patients, potential impact on pharma stock valuations.
SpaceX eyes $20B debt sale, boasts $100.8B cash pile. Investors eye valuation amid funding needs.
Sponsored
Must Read